UTHR – United Therapeutics Corporation

United Therapeutics Corporation

UTHR

$493.99

Name : United Therapeutics Corporation

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $22,341,320,704.00

EPSttm : 26.38

United Therapeutics Corporation

$493.99

1.12%

$5.48

Float Short %

4.26

Margin Of Safety %

-4

Put/Call OI Ratio

1.21

EPS Next Q Diff

-0.14

EPS Last/This Y

0.66

EPS This/Next Y

1.39

Price

494.05

Target Price

526.09

Analyst Recom

1.69

Performance Q

22.54

Relative Volume

0.8

Beta

0.84

Ticker: UTHR

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-13	UTHR	462.32	1.25	0.03	39693
2025-11-14	UTHR	466.85	1.24	0.58	39896
2025-11-17	UTHR	473.29	1.24	0.46	40355
2025-11-18	UTHR	476.85	1.24	0.44	40447
2025-11-19	UTHR	476.94	1.24	0.29	40579
2025-11-20	UTHR	475.04	1.24	0.35	40612
2025-11-21	UTHR	474.64	1.24	1.26	40730
2025-11-24	UTHR	476.89	1.39	0.56	24050
2025-11-25	UTHR	485.81	1.38	0.60	24185
2025-11-26	UTHR	488.43	1.26	2.24	26773
2025-12-01	UTHR	480.17	1.18	0.98	28877
2025-12-02	UTHR	474.42	1.18	0.13	28870
2025-12-03	UTHR	481.31	1.18	0.71	28876
2025-12-04	UTHR	484.3	1.18	0.18	28874
2025-12-05	UTHR	489.12	1.18	3.85	28907
2025-12-08	UTHR	479.53	1.19	2.89	29159
2025-12-09	UTHR	476.74	1.20	6.75	29196
2025-12-10	UTHR	484.55	1.20	3.94	29214
2025-12-11	UTHR	488.98	1.20	2.74	29216
2025-12-12	UTHR	494.29	1.21	0.16	29356
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-13	UTHR	462.40	16.0	60.2	27.11
2025-11-14	UTHR	466.70	16.0	76.1	27.11
2025-11-17	UTHR	471.94	16.0	78.7	27.11
2025-11-18	UTHR	476.54	16.0	76.0	27.11
2025-11-19	UTHR	476.54	16.0	56.1	27.11
2025-11-20	UTHR	475.02	17.1	49.8	27.10
2025-11-21	UTHR	474.66	17.1	54.7	27.10
2025-11-24	UTHR	476.89	17.1	67.0	27.10
2025-11-25	UTHR	485.77	17.1	94.8	27.10
2025-11-26	UTHR	488.71	17.1	68.7	27.10
2025-12-01	UTHR	479.95	17.1	30.8	27.10
2025-12-02	UTHR	474.14	17.1	30.1	27.10
2025-12-03	UTHR	480.96	17.1	85.9	27.10
2025-12-04	UTHR	484.33	17.1	70.7	27.10
2025-12-05	UTHR	489.31	17.1	78.4	27.10
2025-12-08	UTHR	479.51	17.1	-	27.10
2025-12-09	UTHR	476.36	17.1	42.8	27.10
2025-12-10	UTHR	484.87	17.1	93.1	27.10
2025-12-11	UTHR	488.77	17.1	73.0	27.10
2025-12-12	UTHR	494.05	17.1	79.6	27.10
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-13	UTHR	-32.46	-3.04	4.04
2025-11-14	UTHR	-32.72	-3.04	4.04
2025-11-17	UTHR	-31.79	-2.61	4.04
2025-11-18	UTHR	-33.41	-2.61	4.04
2025-11-19	UTHR	-33.41	-2.61	4.04
2025-11-20	UTHR	-33.32	-2.61	4.04
2025-11-21	UTHR	-33.32	-2.61	4.04
2025-11-24	UTHR	-33.56	-5.49	4.05
2025-11-25	UTHR	-32.58	-5.49	4.05
2025-11-26	UTHR	-34.17	-5.49	3.97
2025-12-01	UTHR	-34.08	-5.53	3.97
2025-12-02	UTHR	-35.52	-5.53	3.97
2025-12-03	UTHR	-35.52	-5.53	3.97
2025-12-04	UTHR	-35.19	-5.53	3.97
2025-12-05	UTHR	-35.41	-5.53	3.97
2025-12-08	UTHR	-35.63	-5.54	3.97
2025-12-09	UTHR	-36.79	-5.54	3.97
2025-12-10	UTHR	-36.79	-5.54	4.26
2025-12-11	UTHR	-36.69	-5.54	4.26
2025-12-12	UTHR	-36.69	-5.54	4.26
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="UTHR" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

7.16

Avg. EPS Est. Current Quarter

6.88

Avg. EPS Est. Next Quarter

7.02

Insider Transactions

-36.69

Institutional Transactions

-5.54

Beta

0.84

Average Sales Estimate Current Quarter

818

Average Sales Estimate Next Quarter

817

Fair Value

471.92

Quality Score

100

Growth Score

Sentiment Score

Actual DrawDown %

-0.3

Max Drawdown 5-Year %

-33

Target Price

526.09

P/E

18.72

Forward P/E

16.27

PEG

1.77

P/S

6.8

P/B

3.22

P/Free Cash Flow

18.96

EPS

26.39

Average EPS Est. Cur. Y

27.1

EPS Next Y. (Est.)

28.49

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

40.65

Relative Volume

0.8

Return on Equity vs Sector %

-7.6

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

0.45

EBIT Estimation

79.6

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”UTHR” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”UTHR” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”UTHR” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”UTHR” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”UTHR” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”UTHR” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”UTHR” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

United Therapeutics Corporation

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 1305

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for treating high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, the company involved in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. United Therapeutics Corporation was incorporated in 1996 and is headquartered in Silver Spring, Maryland.

stock quote shares UTHR – United Therapeutics Corporation Stock Price stock today

news today UTHR – United Therapeutics Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch UTHR – United Therapeutics Corporation yahoo finance google finance

stock history UTHR – United Therapeutics Corporation invest stock market

stock prices UTHR premarket after hours

ticker UTHR fair value insiders trading

UTHR – United Therapeutics Corporation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: UTHR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y